Stage and regression time of radiological changes in patients treated for small cell lung cancer
Wiatr, E.; Bestry, I.; Zych, J.; Grymiński, J.
Pneumonologia i Alergologia Polska 61(1-2): 46-51
1993
ISSN/ISBN: 0867-7077 PMID: 8388759 Document Number: 406036
Document emailed within 1 workday
Related Documents
Pan, Y.; Wang, Y.L.; Wang, Y.G.; Wang, D.L. 2019: The pathological characteristics and outcomes of 40 surgically treated stage M1b non-small cell lung cancer patients Zhonghua Zhong Liu Za Zhi 41(1): 63-67Sahin, C.; Omar, M.; Tunca, H.; Kalemci, S.; Ozseker, B.; Akbaba, G.; Tanriverdi, O. 2015: Weight loss at the time of diagnosis is not associated with prognosis in patients with advanced-stage non-small cell lung cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 20(6): 1576-1584
Neill, H.B.; Miller, A.A.; Clamon, G.H.; Perry, M.C.; Crawford, J.; Green, M.R. 1997: A phase Ii study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancer Seminars in Oncology 24(4 Suppl 12: S12
Ziske, C.; Gorschlüter, M.; Mey, U.; Offergeld, R.; Glasmacher, A.; Schmidt-Wolf, I.G.H. 2002: Sequential high-dose chemotherapy with autologous stem cell support in patients with limited-stage small cell lung cancer Anticancer Research 22(6b): 3723-3726
Uchikov, A.; Murdzhev, K.; Batashki, I.; Prisadov, G.; Uchikova, E. 2007: Remote results in operated patients with non-small cell lung cancer in IIi clinical stage Khirurgiia 5: 41-42
Alsan Cetin, I.; Akgun, Z.; Atasoy, B.M.; Fulden Yumuk, P.; Abacioglu, U. 2013: Who may benefit from prophylactic cranial irradiation amongst stage III non-small cell lung cancer patients? Journal of BUON: Official Journal of the Balkan Union of Oncology 18(2): 453-458
Cohen, M.H. 1983: Is thoracic radiation therapy necessary for patients with limited-stage small cell lung cancer? no Cancer Treatment Reports 67(3): 217-221
Fram, R.; Skarin, A.; Balikian, J.; Amato, D.; Leslie, N.; Malcolm, A.; Frei, E. 1985: Combination chemotherapy followed by radiation therapy in patients with regional stage IIi unresectable non-small cell lung cancer Cancer Treatment Reports 69(6): 587-590
Dell'amore, A.; Monteverde, M.; Caroli, G.; Sanna, S.; Stella, F.; Bini, A. 2013: Surgical results and survival of older patients with unsuspected N₂ (stage IIIA) non-small cell lung cancer Il Giornale di Chirurgia 34(3): 53-58
Evans, W.K. 1997: Cost-effectiveness of gemcitabine in stage IV non-small cell lung cancer: an estimate using the Population Health Model lung cancer module Seminars in Oncology 24(2 Suppl 7: S7
Graziano, S.L.; Tatum, A.H.; Newman, N.B.; Oler, A.; Kohman, L.J.; Veit, L.J.; Gamble, G.P.; Coleman, M.J.; Barmada, S.; O'Lear, S. 1994: The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage i and Ii non-small cell lung cancer Cancer Research 54(11): 2908-2913
Mańdziuk, S.ła.; Dudzisz-Sledź, M.; Korszeń-Pilecka, I.; Milanowski, J.; Wojcierowski, J.; Korobowicz, E. 2003: Expression of p53 gene in stage IIIA non-small cell lung cancer in patients after neoadjuvant chemotherapy with Vepesid and Cisplatin Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 58(1): 154-157
Cihan, Y.B. 2014: Do trace element levels have prognostic value in non-small cell lung cancer patients treated with chemoradiotherapy? Journal of Buon: Official Journal of the Balkan Union of Oncology 19(3): 749-756
Nishikawa, M.; Kusano, N.; Yoshimoto, N.; Ito, M.; Kakemizu, N.; Nozaki, M.; Fujiwara, M.; Momiyama, M.; Kido, Y. 2006: Prolonged survival of gefitinib treatment in patients with advanced and previously treated non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(10): 1437-1440
Fujita, A.; Igami, Y.; Takabatake, H.; Tagaki, S.; Yamamoto, R.; Sekine, K. 1999: Period of time patients with advanced non-small cell lung cancer could remain at home during CIC--therapy (cisplatin + ifosfamide + CPT-11) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(6): 805-811
Rusch, V.W.; Albain, K.S.; Crowley, J.J.; Rice, T.W.; Lonchyna, V.; McKenna, R.; Livingston, R.B.; Griffin, B.R.; Benfield, J.R. 1993: Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. A Southwest Oncology Group trial Journal of Thoracic and Cardiovascular Surgery 105(1): 97
2015: (S040) has severe acute esophagitis been reduced by 21st century treatment modalities among patients with limited-stage small-cell lung cancer? Oncology 29(4 Suppl. 1)
2016: (S040) Nadir White Blood Cell, Absolute Neutrophil, and Absolute Lymphocyte Counts During Concurrent Chemoradiation Therapy Predicted Worse Outcomes in Patients With Limited-Stage Small-Cell Lung Cancer Oncology 30 Suppl
Rendina, E.A.; Venuta, F.; De Giacomo, T.; Furio Coloni, G. 2001: Stage IIIB non-small-cell lung cancer Chest Surgery Clinics of North America 11(1): 101-119 Viii
Hou, H.-l.; Hao, J.-l.; Pang, Q.-s.; Wang, P. 2010: Concurrent chemoradiotherapy for stage IIi non-small cell lung cancer Zhonghua Yi Xue Za Zhi 90(29): 2068-2070